ELI LILLY AND COMPANY Selling, General and Administrative Expense
ELI LILLY AND COMPANY (LLY) reported Selling, General and Administrative Expense of $3.43 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- ELI LILLY AND COMPANY selling, general and administrative expense for the quarter ending 2026-06-30 was $3.43B, a 24.59% increase year-over-year.
- ELI LILLY AND COMPANY selling, general and administrative expense for the quarter ending 2026-03-31 was $2.93B, a 18.88% increase year-over-year.
- ELI LILLY AND COMPANY selling, general and administrative expense for the quarter ending 2025-12-31 was $3.13B, a 29.15% increase year-over-year.
- ELI LILLY AND COMPANY selling, general and administrative expense for the quarter ending 2025-09-30 was $2.74B, a 30.52% increase year-over-year.
- ELI LILLY AND COMPANY selling, general and administrative expense for fiscal 2025 was $11.09B, a 29.09% increase from fiscal 2024.
- ELI LILLY AND COMPANY selling, general and administrative expense for fiscal 2024 was $8.59B, a 16.07% increase from fiscal 2023.
- ELI LILLY AND COMPANY selling, general and administrative expense for fiscal 2023 was $7.40B, a 14.96% increase from fiscal 2022.
- ELI LILLY AND COMPANY selling, general and administrative expense for fiscal 2022 was $6.44B, a 0.14% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.43B 10-Q · filed 2026-08-05 | $6.36B 10-Q · filed 2026-08-05 | $9.50B derived: sum of 3 quarters · filed 2026-08-05 | $12.24B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.93B 10-Q · filed 2026-04-30 | $6.07B derived: sum of 2 quarters · filed 2026-04-30 | $8.81B derived: sum of 3 quarters · filed 2026-04-30 | $11.56B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $3.13B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $5.87B derived: sum of 2 quarters · filed 2026-02-12 | $8.63B derived: sum of 3 quarters · filed 2026-08-05 | $11.09B 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $2.74B 10-Q · filed 2025-10-30 | $5.49B derived: sum of 2 quarters · filed 2026-08-05 | $7.96B 10-Q · filed 2025-10-30 | $10.39B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $2.75B 10-Q · filed 2026-08-05 | $5.22B 10-Q · filed 2026-08-05 | $5.22B 10-Q · filed 2025-08-07 | $7.65B derived: sum of 3 quarters · filed 2026-08-05 | $9.75B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $2.47B 10-Q · filed 2026-04-30 | $2.47B 10-Q · filed 2025-05-01 | $4.89B derived: sum of 2 quarters · filed 2026-04-30 | $6.99B derived: sum of 3 quarters · filed 2026-04-30 | $9.11B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $2.42B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.52B derived: sum of 2 quarters · filed 2026-02-12 | $6.64B derived: sum of 3 quarters · filed 2026-02-12 | $8.59B 10-K · filed 2026-02-12 | $8.59B 10-K · filed 2025-02-19 | |||
| 2024-09-30 | $2.10B 10-Q · filed 2025-10-30 | $4.22B derived: sum of 2 quarters · filed 2025-10-30 | $6.17B 10-Q · filed 2025-10-30 | $8.09B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $2.12B 10-Q · filed 2025-08-07 | $4.07B 10-Q · filed 2025-08-07 | $6.00B derived: sum of 3 quarters · filed 2026-02-12 | $7.80B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $1.95B 10-Q · filed 2025-05-01 | $3.88B derived: sum of 2 quarters · filed 2026-02-12 | $5.68B derived: sum of 3 quarters · filed 2026-02-12 | $7.61B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.73B derived: sum of 2 quarters · filed 2026-02-12 | $5.65B derived: sum of 3 quarters · filed 2026-02-12 | $7.40B 10-K · filed 2026-02-12 | $7.40B 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $1.80B 10-Q · filed 2024-10-30 | $3.73B derived: sum of 2 quarters · filed 2024-10-30 | $5.48B 10-Q · filed 2024-10-30 | $7.12B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | $1.93B 10-Q · filed 2024-08-08 | $3.67B 10-Q · filed 2024-08-08 | $5.32B derived: sum of 3 quarters · filed 2025-02-19 | $6.93B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | $1.75B 10-Q · filed 2024-04-30 | $3.39B derived: sum of 2 quarters · filed 2025-02-19 | $5.01B derived: sum of 3 quarters · filed 2025-02-19 | $6.63B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $1.64B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $3.26B derived: sum of 2 quarters · filed 2025-02-19 | $4.88B derived: sum of 3 quarters · filed 2025-02-19 | $6.44B 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | $1.61B 10-Q · filed 2023-11-02 | $3.24B derived: sum of 2 quarters · filed 2023-11-02 | $4.80B 10-Q · filed 2023-11-02 | $6.39B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $1.63B 10-Q · filed 2023-08-08 | $3.18B 10-Q · filed 2023-08-08 | $4.78B derived: sum of 3 quarters · filed 2024-02-21 | $6.35B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $1.56B 10-Q · filed 2023-04-27 | $3.15B derived: sum of 2 quarters · filed 2024-02-21 | $4.73B derived: sum of 3 quarters · filed 2024-02-21 | $6.41B derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $3.17B derived: sum of 2 quarters · filed 2024-02-21 | $4.86B derived: sum of 3 quarters · filed 2024-02-21 | $6.43B 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $1.58B 10-Q · filed 2022-11-01 | $3.26B derived: sum of 2 quarters · filed 2022-11-01 | $4.84B 10-Q · filed 2022-11-01 | $6.39B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $1.69B 10-Q · filed 2022-08-04 | $3.26B 10-Q · filed 2022-08-04 | $4.82B derived: sum of 3 quarters · filed 2023-02-22 | $6.38B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $1.58B 10-Q · filed 2022-04-29 | $3.13B derived: sum of 2 quarters · filed 2023-02-22 | $4.70B derived: sum of 3 quarters · filed 2023-02-22 | $6.15B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $1.55B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.12B derived: sum of 2 quarters · filed 2023-02-22 | $4.57B derived: sum of 3 quarters · filed 2023-02-22 | $6.12B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $1.57B 10-Q · filed 2021-10-27 | $3.02B derived: sum of 2 quarters · filed 2021-10-27 | $4.57B 10-Q · filed 2021-10-27 | $6.27B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $1.45B 10-Q · filed 2021-08-03 | $3.00B 10-Q · filed 2021-08-03 | $4.70B derived: sum of 3 quarters · filed 2022-02-23 | $6.11B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $1.55B 10-Q · filed 2021-04-30 | $3.25B derived: sum of 2 quarters · filed 2022-02-23 | $4.66B derived: sum of 3 quarters · filed 2022-02-23 | $6.25B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.70B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.11B derived: sum of 2 quarters · filed 2022-02-23 | $4.70B derived: sum of 3 quarters · filed 2022-02-23 | $6.21B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $1.41B 10-Q · filed 2020-10-28 | $3.00B derived: sum of 2 quarters · filed 2020-10-28 | $4.52B 10-Q · filed 2020-10-28 | $6.21B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $1.59B 10-Q · filed 2020-07-31 | $3.10B 10-Q · filed 2020-07-31 | $4.80B derived: sum of 3 quarters · filed 2021-02-17 | $6.25B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $1.52B 10-Q · filed 2020-05-01 | $3.21B derived: sum of 2 quarters · filed 2021-02-17 | $4.67B derived: sum of 3 quarters · filed 2021-02-17 | $6.15B derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $1.69B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $3.15B derived: sum of 2 quarters · filed 2021-02-17 | $4.64B derived: sum of 3 quarters · filed 2021-02-17 | $5.98B 10-K · filed 2021-02-17 | $6.63B 10-K · filed 2019-02-19 | |||
| 2018-09-30 | $1.46B 10-Q · filed 2019-10-25 | $1.62B 10-Q · filed 2018-11-06 | $2.94B derived: sum of 2 quarters · filed 2019-10-25 | $4.28B 10-Q · filed 2019-10-25 | $4.77B 10-Q · filed 2018-11-06 | $5.39B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-06-30 | $1.49B 10-Q · filed 2019-08-02 | $1.65B 10-Q · filed 2018-07-25 | $2.82B 10-Q · filed 2019-08-02 | $3.15B 10-Q · filed 2018-07-25 | $3.93B derived: sum of 3 quarters · filed 2020-02-19 | $5.51B derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $1.34B 10-Q · filed 2019-05-02 | $1.50B 10-Q · filed 2018-04-27 | $2.44B derived: sum of 2 quarters · filed 2020-02-19 | $4.02B derived: sum of 3 quarters · filed 2020-02-19 | $5.75B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $2.68B derived: sum of 2 quarters · filed 2020-02-19 | $4.41B derived: sum of 3 quarters · filed 2020-02-19 | $5.98B 10-K · filed 2020-02-19 | $6.59B 10-K · filed 2018-02-20 | |||
| 2017-09-30 | $1.58B 10-Q · filed 2018-11-06 | $1.56B 10-Q · filed 2017-10-27 | $3.31B derived: sum of 2 quarters · filed 2018-11-06 | $4.88B 10-Q · filed 2018-11-06 | $4.81B 10-Q · filed 2017-10-27 | $6.06B derived: sum of 4 quarters · filed 2019-10-24 | ||
| 2017-06-30 | $1.73B 10-Q · filed 2018-07-25 | $1.71B 10-Q · filed 2017-07-28 | $3.30B 10-Q · filed 2018-07-25 | $3.25B 10-Q · filed 2017-07-28 | $4.48B derived: sum of 3 quarters · filed 2019-10-24 | $6.04B derived: sum of 4 quarters · filed 2019-10-24 | ||
| 2017-03-31 | $1.57B 10-Q · filed 2018-04-27 | $1.54B 10-Q · filed 2017-05-01 | $2.75B derived: sum of 2 quarters · filed 2019-10-24 | $4.31B derived: sum of 3 quarters · filed 2019-10-24 | $5.94B derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2016-12-31 | $1.18B derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $2.75B derived: sum of 2 quarters · filed 2019-10-24 | $4.37B derived: sum of 3 quarters · filed 2019-10-24 | $5.84B 8-K · filed 2019-10-24 | $6.45B 10-K · filed 2017-02-21 | |||
| 2016-09-30 | $1.57B 10-Q · filed 2017-10-27 | $3.19B derived: sum of 2 quarters · filed 2017-10-27 | $4.66B 10-Q · filed 2017-10-27 | $6.46B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-06-30 | $1.62B 10-Q · filed 2017-07-28 | $3.10B 10-Q · filed 2017-07-28 | $4.89B derived: sum of 3 quarters · filed 2018-02-20 | $6.47B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-03-31 | $1.47B 10-Q · filed 2017-05-01 | $3.27B derived: sum of 2 quarters · filed 2018-02-20 | $4.85B derived: sum of 3 quarters · filed 2018-02-20 | $6.48B derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2015-12-31 | $1.80B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $3.37B derived: sum of 2 quarters · filed 2018-02-20 | $5.01B derived: sum of 3 quarters · filed 2018-02-20 | $6.53B 10-K · filed 2018-02-20 | ||||
| 2015-09-30 | $1.58B 10-Q · filed 2016-10-28 | $3.21B derived: sum of 2 quarters · filed 2016-10-28 | $4.73B 10-Q · filed 2016-10-28 | $6.53B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | $1.64B 10-Q · filed 2016-07-28 | $3.16B 10-Q · filed 2016-07-28 | $4.96B derived: sum of 3 quarters · filed 2017-02-21 | $6.63B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $1.52B 10-Q · filed 2016-04-29 | $3.32B derived: sum of 2 quarters · filed 2017-02-21 | $5.00B derived: sum of 3 quarters · filed 2017-02-21 | $6.66B derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $1.80B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $3.47B derived: sum of 2 quarters · filed 2017-02-21 | $5.14B derived: sum of 3 quarters · filed 2017-02-21 | $6.62B 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $1.67B 10-Q · filed 2015-10-30 | $3.34B derived: sum of 2 quarters · filed 2015-10-30 | $4.82B 10-Q · filed 2015-10-30 | $6.77B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $1.66B 10-Q · filed 2015-07-30 | $3.15B 10-Q · filed 2015-07-30 | $5.10B derived: sum of 3 quarters · filed 2016-02-19 | $6.75B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $1.48B 10-Q · filed 2015-04-30 | $3.44B derived: sum of 2 quarters · filed 2016-02-19 | $5.09B derived: sum of 3 quarters · filed 2016-02-19 | $6.96B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $1.95B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $3.61B derived: sum of 2 quarters · filed 2016-02-19 | $5.47B derived: sum of 3 quarters · filed 2016-02-19 | $7.13B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $1.65B 10-Q · filed 2014-10-29 | $3.52B derived: sum of 2 quarters · filed 2014-10-29 | $5.17B 10-Q · filed 2014-10-29 | $7.15B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $1.87B 10-Q · filed 2014-07-28 | $3.52B 10-Q · filed 2014-07-28 | $5.50B derived: sum of 3 quarters · filed 2015-02-19 | $7.25B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $1.65B 10-Q · filed 2014-04-28 | $3.63B derived: sum of 2 quarters · filed 2015-02-19 | $5.39B derived: sum of 3 quarters · filed 2015-02-19 | $7.32B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $1.98B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $3.73B derived: sum of 2 quarters · filed 2015-02-19 | $5.67B derived: sum of 3 quarters · filed 2015-02-19 | $7.51B 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $1.76B 10-Q · filed 2013-10-30 | $3.69B derived: sum of 2 quarters · filed 2013-10-30 | $5.54B 10-Q · filed 2013-10-30 | $7.67B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-06-30 | $1.93B 10-Q · filed 2013-07-26 | $3.78B 10-Q · filed 2013-07-26 | $5.91B derived: sum of 3 quarters · filed 2014-02-19 | $7.83B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2012-03-31 | $1.85B 10-Q · filed 2013-04-26 | $3.98B derived: sum of 2 quarters · filed 2014-02-19 | $5.90B derived: sum of 3 quarters · filed 2014-02-19 | $7.94B derived: sum of 4 quarters · filed 2014-02-19 | ||||
| 2011-12-31 | $2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $4.05B derived: sum of 2 quarters · filed 2014-02-19 | $6.09B derived: sum of 3 quarters · filed 2014-02-19 | $7.88B 10-K · filed 2014-02-19 | ||||
| 2011-09-30 | $1.92B 10-Q · filed 2012-10-26 | $3.96B derived: sum of 2 quarters · filed 2012-10-26 | $5.75B 10-Q · filed 2012-10-26 | $7.74B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $2.04B 10-Q · filed 2012-07-27 | $3.83B 10-Q · filed 2012-07-27 | $5.82B derived: sum of 3 quarters · filed 2013-02-21 | $7.51B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $1.79B 10-Q · filed 2012-04-30 | $3.77B derived: sum of 2 quarters · filed 2013-02-21 | $5.47B derived: sum of 3 quarters · filed 2013-02-21 | $7.22B derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $1.99B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $3.68B derived: sum of 2 quarters · filed 2013-02-21 | $5.44B derived: sum of 3 quarters · filed 2013-02-21 | $7.05B 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $1.69B 10-Q · filed 2011-10-28 | $3.45B derived: sum of 2 quarters · filed 2011-10-28 | $5.06B 10-Q · filed 2011-10-28 | $7.02B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-06-30 | $1.76B 10-Q · filed 2011-07-29 | $3.37B 10-Q · filed 2011-07-29 | $5.32B derived: sum of 3 quarters · filed 2012-02-24 | $7.02B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-03-31 | $1.61B 10-Q · filed 2011-04-29 | $3.57B derived: sum of 2 quarters · filed 2012-02-24 | $5.27B derived: sum of 3 quarters · filed 2012-02-24 | $6.98B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2009-12-31 | $1.95B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $3.66B derived: sum of 2 quarters · filed 2012-02-24 | $5.36B derived: sum of 3 quarters · filed 2012-02-24 | $6.89B 10-K · filed 2012-02-24 | ||||
| 2009-09-30 | $1.70B 10-Q · filed 2010-10-29 | $3.41B derived: sum of 2 quarters · filed 2010-10-29 | $4.94B 10-Q · filed 2010-10-29 | $6.67B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-06-30 | $1.71B 10-Q/A · filed 2010-08-02 | $3.24B 10-Q/A · filed 2010-08-02 | $4.96B derived: sum of 3 quarters · filed 2011-02-22 | $6.61B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-03-31 | $1.53B 10-Q · filed 2010-07-30 | $3.26B derived: sum of 2 quarters · filed 2011-02-22 | $4.91B derived: sum of 3 quarters · filed 2011-02-22 | $6.61B derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2008-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $3.38B derived: sum of 2 quarters · filed 2011-02-22 | $5.08B derived: sum of 3 quarters · filed 2011-02-22 | $6.63B 10-K · filed 2011-02-22 | ||||
| 2008-09-30 | $1.65B 10-Q · filed 2009-10-30 | $3.35B derived: sum of 2 quarters · filed 2009-10-30 | $4.90B 10-Q · filed 2009-10-30 | |||||
| 2008-06-30 | $1.70B 10-Q · filed 2009-07-31 | $3.25B 10-Q · filed 2009-07-31 | ||||||
| 2007-12-31 | $6.10B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |